Tata Chemicals

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE092A01019
  • NSEID: TATACHEM
  • BSEID: 500770
INR
611.20
-2.15 (-0.35%)
BSENSE

Sep 08, 10:40 AM

BSE+NSE Vol: 1.08 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.08 lacs (-49.82%) Volume

Shareholding (Jun 2026)

FII

12.07%

Held by 150 FIIs

DII

21.15%

Held by 29 DIIs

Promoter

37.98%

Which are the latest news on Tata Chemicals?

07-Sep-2026

Why is Tata Chemicals Ltd. falling/rising?

06-Sep-2026

As of 05-Sep, Tata Chemicals Ltd. is facing a decline in stock price, currently at 625.35, reflecting a significant underperformance compared to the sector and the benchmark Sensex over various periods. Contributing factors include weak long-term fundamentals, low profitability, and diminished investor confidence.

As of 05-Sep, Tata Chemicals Ltd. is experiencing a decline in its stock price, currently at 625.35, which reflects a change of -16.6 (-2.59%). The stock has underperformed the sector by 3.95% today and has fallen after two consecutive days of gains. The stock touched an intraday low of Rs 624.15, indicating a drop of 2.77%. <BR><BR>The company's performance over various periods shows significant underperformance compared to the benchmark Sensex. Over the past week, the stock has decreased by 4.75%, and in the last month, it has fallen by 6.41%. Year-to-date, the decline stands at 18.30%, and over the past year, the stock has plummeted by 33.37%, while the Sensex has only decreased by 5.21%. This consistent underperformance is further highlighted by a staggering 42.60% drop over the last three years, contrasting sharply with the Sensex's gain of 16.59% during the same period.<BR><BR>Additional factors contributing to the stock's decline include weak long-term fundamental strength, with a -14.18% CAGR growth in operating profits over the last five years and negative results reported for the last three consecutive quarters. The company's return on equity is low at an average of 5.13%, indicating low profitability per unit of shareholders' funds. Moreover, the stock is trading below all moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend.<BR><BR>Investor participation has also diminished, with a delivery volume drop of 45.66% against the 5-day average, suggesting a lack of confidence among investors. Despite high institutional holdings at 33.22%, which usually indicates a level of confidence in the stock, the overall financial performance and market trends are leading to a negative sentiment surrounding Tata Chemicals Ltd., resulting in its falling stock price.

View full answer

Who are in the management team of Tata Chemicals?

01-Sep-2026

The management team of Tata Chemicals includes key individuals such as R Mukundan (Managing Director & CEO), Rajiv Chandan (Company Secretary), and Ratan N Tata (Chairman Emeritus), among others, bringing diverse expertise to the company.

The management team of Tata Chemicals includes the following key individuals:<BR><BR>1. **Rajiv Chandan** - Company Secretary & Compliance Officer<BR>2. **R Mukundan** - Managing Director & CEO<BR>3. **Vibha Paul Rishi** - Independent Director<BR>4. **S Padmanabhan** - Director<BR>5. **Ratan N Tata** - Chairman Emeritus<BR>6. **Padmini Khare Kaicker** - Independent Director<BR>7. **Zarir Langrana** - Executive Director<BR>8. **C V Natraj** - Independent Director<BR>9. **K B S Anand** - Independent Director<BR>10. **N Chandrasekaran** - Chairman (Non-Executive)<BR>11. **Rajiv Dube** - Independent Director<BR><BR>This diverse team brings a wealth of experience and expertise to the company.

View full answer

What does Tata Chemicals do?

01-Sep-2026

Tata Chemicals Ltd. is a small-cap company focused on sustainable chemistry solutions in the commodity chemicals industry, reporting net sales of ₹4,255 Cr and a net loss of ₹17 Cr for June 2026. Key metrics include a market cap of ₹16,498 Cr, a dividend yield of 1.68%, and a debt-to-equity ratio of 0.32.

Overview:<BR>Tata Chemicals Ltd. is a science-led sustainable chemistry solutions company operating in the commodity chemicals industry and categorized as a small-cap entity.<BR><BR>History:<BR>Tata Chemicals was incorporated in the early 20th century and has undergone various status changes over the years. The latest quarterly results reported net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 4,255 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: -17 Cr (Quarterly Results - Jun 2026)<BR>- Market-cap: INR 16,498 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A (Loss Making)<BR>- Industry P/E: 69<BR>- Dividend Yield: 1.68%<BR>- Debt Equity: 0.32<BR>- Return on Equity: 0.18%<BR>- Price to Book: 0.79<BR><BR>Contact Details:<BR>Address: Bombay House, 24 Homi Mody Street Fort Mumbai Maharashtra : 400001<BR>Tel: 91-22-66658282<BR>Email: investors@tatachemicals.com<BR>Website: http://www.tatachemicals.com

View full answer

Who are the peers of the Tata Chemicals?

01-Sep-2026

Tata Chemicals' peers include India Glycols, Tanfac Inds., Gujarat Alkalies, GHCL, Chemplast Sanmar, J.G.Chemicals, Fischer Medical, and Thirumalai Chem. Key insights show varying management risks, growth rates, and capital structures among these companies, with India Glycols leading in 1-year returns at 41.38% and Fischer Medical at -66.23%.

Peers: The peers of Tata Chemicals are India Glycols, Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, J.G.Chemicals, Fischer Medical, and Thirumalai Chem.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Tanfac Inds., Gujarat Alkalies, Grauer & Weil, J.G.Chemicals, Fischer Medical, and Thirumalai Chem. Below Average growth is noted for Tata Chemicals, India Glycols, Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, Chemplast Sanmar, and Thirumalai Chem, while Good growth is seen at J.G.Chemicals and Fischer Medical. Capital Structure is Excellent for Tanfac Inds., Gujarat Alkalies, GHCL, Grauer & Weil, and J.G.Chemicals, while Average is noted for Tata Chemicals, and Below Average for India Glycols, Chemplast Sanmar, and Thirumalai Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 41.38%, while the lowest is Fischer Medical at -66.23%. Tata Chemicals' own 1-year return is -30.25%, which is better than Fischer Medical but worse than India Glycols. Additionally, the six-month return is negative for GHCL, Chemplast Sanmar, Fischer Medical, and Thirumalai Chem.

View full answer

How big is Tata Chemicals?

01-Sep-2026

As of 31st August, Tata Chemicals Ltd. has a market capitalization of 16,498.00 Cr and reported net sales of 15,120.00 Cr, with a loss of 2,165.00 Cr over the latest four quarters.

As of 31st August, Tata Chemicals Ltd. has a market capitalization of 16,498.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Tata Chemicals reported net sales of 15,120.00 Cr. However, the company experienced a loss of 2,165.00 Cr during the same period.<BR><BR>The latest reporting period for the balance sheet is March 2026, with shareholder's funds amounting to 21,206.00 Cr and total assets valued at 38,998.00 Cr.

View full answer

Are Tata Chemicals Ltd. latest results good or bad?

28-Jul-2026

Tata Chemicals Ltd.'s latest Q1 FY27 results show strong revenue growth of 14.41% to ₹4,255 crores, but the company reported a net loss of ₹17 crores, down from a profit of ₹252 crores last year, indicating significant operational challenges and declining profitability. Overall, these results are viewed unfavorably by investors.

Tata Chemicals Ltd.'s latest results for Q1 FY27 present a mixed picture, but overall, they indicate significant challenges for the company. On one hand, the company achieved its highest-ever quarterly revenue, with net sales reaching ₹4,255 crores, reflecting a year-on-year growth of 14.41%. However, this impressive top-line growth is overshadowed by a substantial net loss of ₹17 crores, a drastic decline from a profit of ₹252 crores in the same quarter last year, marking a year-on-year deterioration of 106.75%.<BR><BR>The operating margin also fell to 13.04%, down from 17.45% a year earlier, indicating increasing pressure on profitability due to rising input costs and unfavorable market conditions. Furthermore, the return on equity (ROE) has dropped to a mere 0.18%, highlighting severe inefficiencies in generating returns for shareholders.<BR><BR>Overall, while Tata Chemicals has demonstrated strong revenue growth, the inability to convert that growth into profit, along with declining margins and weak return ratios, paints a concerning picture of the company's financial health. Investors are likely to view these results as unfavorable, given the significant losses and operational challenges the company is facing.

View full answer

Should I buy, sell or hold Tata Chemicals Ltd.?

28-Jul-2026

When is the next results date for Tata Chemicals Ltd.?

21-Jul-2026

The next results date for Tata Chemicals Ltd. is 27 July 2026.

The next results date for Tata Chemicals Ltd. is scheduled for 27 July 2026.

View full answer

Is Tata Chemicals technically bullish or bearish?

29-Nov-2025

As of November 28, 2025, Tata Chemicals exhibits a strong bearish trend, supported by multiple indicators including bearish MACD, Bollinger Bands, and moving averages across weekly and monthly time frames.

As of 28 November 2025, the technical trend for Tata Chemicals has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators. The MACD is bearish on both the weekly and monthly time frames, and Bollinger Bands also reflect a bearish outlook in both time frames. Daily moving averages confirm a bearish trend, while the KST is bearish on both weekly and monthly levels. Dow Theory indicates a mildly bearish stance on the weekly and monthly charts, and the OBV is also mildly bearish. Overall, the combination of these indicators suggests a strong bearish sentiment for Tata Chemicals.

View full answer

Is Tata Chemicals overvalued or undervalued?

07-Nov-2025

As of November 6, 2025, Tata Chemicals is considered overvalued due to its high PE ratio of 60.22 and poor stock performance, significantly underperforming the Sensex with a return of -24.10%.

As of 6 November 2025, Tata Chemicals' valuation grade has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its high PE ratio of 60.22, an EV to EBIT of 38.86, and a notably low Price to Book Value of 0.10. These ratios suggest that the market is pricing the stock at a premium compared to its underlying fundamentals.<BR><BR>In comparison to its peers, Tata Chemicals stands out with a significantly higher PE ratio than Adani Enterprises, which has a PE of 127.79, and is also more expensive than DCM Shriram, which is valued attractively with a PE of 26.89. Furthermore, Tata Chemicals has underperformed the Sensex significantly over the past year, with a stock return of -24.10% compared to the Sensex's 3.65% return. Overall, the data supports the conclusion that Tata Chemicals is overvalued in the current market environment.

View full answer

How has been the historical performance of Tata Chemicals?

01-Nov-2025

Tata Chemicals has shown a declining trend in net sales and profitability, with net sales dropping from 16,789 Cr in Mar'23 to 14,887 Cr in Mar'25, and profit after tax decreasing from 381 Cr to 200 Cr in the same period. The company's operating profit margin also fell significantly, indicating reduced operational efficiency.

Answer:<BR>The historical performance of Tata Chemicals shows a fluctuating trend in net sales and profitability over the years, with a notable decline in recent periods.<BR><BR>Breakdown:<BR>Tata Chemicals reported net sales of 14,887.00 Cr in Mar'25, down from 15,421.00 Cr in Mar'24 and 16,789.00 Cr in Mar'23, indicating a downward trend from a peak in Mar'23. The total operating income followed a similar pattern, with a decrease to 14,887.00 Cr in Mar'25 from 15,421.00 Cr in Mar'24. Operating profit (PBDIT) also decreased significantly to 2,178.00 Cr in Mar'25 from 3,133.00 Cr in Mar'24 and 4,040.00 Cr in Mar'23, reflecting a decline in operational efficiency, as evidenced by the operating profit margin dropping to 13.12% in Mar'25 from 18.46% in Mar'24. Profit before tax fell sharply to 367.00 Cr in Mar'25 from 762.00 Cr in Mar'24, and profit after tax decreased to 200.00 Cr from 381.00 Cr in the same period. The consolidated net profit also declined to 235.00 Cr in Mar'25 from 268.00 Cr in Mar'24, contrasting sharply with the high of 2,317.00 Cr in Mar'23. On the balance sheet, total assets increased to 37,750.00 Cr in Mar'25 from 36,711.00 Cr in Mar'24, while total liabilities also rose to 37,750.00 Cr from 36,711.00 Cr, indicating a consistent leverage level. Cash flow from operating activities decreased to 1,761.00 Cr in Mar'25 from 3,016.00 Cr in Mar'24, contributing to a net cash inflow of 123.00 Cr, a recovery from a net outflow of -83.00 Cr in Mar'24. Overall, Tata Chemicals has experienced significant fluctuations in its financial performance, particularly in profitability and cash flow, over the past few years.

View full answer

Who are the top shareholders of the Tata Chemicals?

17-Jul-2025

The top shareholders of Tata Chemicals include Tata Sons Private Limited with 31.9%, mutual funds with 9.15%, foreign institutional investors at 13.3%, and individual investors holding 22.92%. There are no pledged promoter holdings, and the Life Insurance Corporation of India - P & Gs Fund is the largest public shareholder with a minimal stake.

The top shareholders of Tata Chemicals include the promoters, with Tata Sons Private Limited holding the largest share at 31.9%. Additionally, mutual funds collectively hold 9.15% through 40 different schemes, while foreign institutional investors (FIIs) own 13.3% across 155 entities. Individual investors account for 22.92% of the holdings. Notably, there are no pledged promoter holdings, and the highest public shareholder is the Life Insurance Corporation of India - P & Gs Fund, which holds a minimal stake.

View full answer

Has Tata Chemicals declared dividend?

06-Jun-2025

Yes, Tata Chemicals has declared a dividend of 110% (₹15 per share) with an ex-date of June 12, 2024. While the dividend yield is 1.61%, total returns over shorter periods have been negative, despite positive long-term performance.

Tata Chemicals Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 110%<BR>- Amount per share: 15<BR>- Ex-date: 12 Jun 2024<BR><BR>Dividend Yield: 1.61%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -16.85%, the dividend return was 0.99%, resulting in a total return of -15.86%.<BR><BR>Over the past year, the price return was -12.38%, the dividend return was 2.34%, leading to a total return of -10.04%.<BR><BR>In the 2-year period, the price return was -6.15%, the dividend return was 2.66%, resulting in a total return of -3.49%.<BR><BR>For the 3-year period, the price return was -1.71%, the dividend return was 5.48%, culminating in a total return of 3.77%.<BR><BR>In the last 4 years, the price return was 24.75%, the dividend return was 7.76%, resulting in a total return of 32.51%.<BR><BR>Over the past 5 years, the price return was 192.35%, the dividend return was 21.34%, leading to a total return of 213.69%.<BR><BR>Overall, Tata Chemicals has declared a significant dividend, but the total returns over shorter periods have been negative, indicating a challenging performance in the near term despite positive long-term returns.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -14.18% CAGR growth in Operating Profits over the last 5 years

  • The company has been able to generate a Return on Equity (avg) of 5.13% signifying low profitability per unit of shareholders funds
2

The company has declared Negative results for the last 3 consecutive quarters

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 15,510 Cr (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

65

stock-summary
Dividend Yield

1.79%

stock-summary
Debt Equity

0.32

stock-summary
Return on Equity

0.18%

stock-summary
Price to Book

0.74

Revenue and Profits:
Net Sales:
4,255 Cr
(Quarterly Results - Jun 2026)
Net Profit:
-17 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.79%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.87%
0%
-14.87%
6 Months
-13.56%
1.61%
-11.95%
1 Year
-35.21%
1.13%
-34.08%
2 Years
-42.16%
2.16%
-40.0%
3 Years
-43.68%
3.54%
-40.14%
4 Years
-45.28%
4.99%
-40.29%
5 Years
-26.56%
7.16%
-19.4%

Latest dividend: 11 per share ex-dividend date: Jun-10-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Tata Chemicals Limited - Other General Purpose

13-Nov-2019 | Source : NSE

Tata Chemicals Limited has informed the Exchange regarding Disclosure of Related Party Transactions for the half year ended September 30, 2019 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Tata Chemicals Limited - Analysts/Institutional Investor Meet/Con. Call Updates

06-Nov-2019 | Source : NSE

Tata Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Tata Chemicals Limited - Press Release

31-Oct-2019 | Source : NSE

Tata Chemicals Limited has informed the Exchange regarding a press release dated October 30, 2019, titled "Press Release on the Financial Results for the second quarter and half year ended September 30, 2019".

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tata Chemicals Ltd. has declared 110% dividend, ex-date: 10 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
6.90%
EBIT Growth (5y)
-14.18%
EBIT to Interest (avg)
3.53
Debt to EBITDA (avg)
2.90
Net Debt to Equity (avg)
0.32
Sales to Capital Employed (avg)
0.54
Tax Ratio
15.33%
Dividend Payout Ratio
-14.79%
Pledged Shares
0
Institutional Holding
33.22%
ROCE (avg)
6.36%
ROE (avg)
5.13%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
65
Price to Book Value
0.74
EV to EBIT
49.52
EV to EBITDA
13.14
EV to Capital Employed
0.80
EV to Sales
1.49
PEG Ratio
NA
Dividend Yield
1.79%
ROCE (Latest)
2.15%
ROE (Latest)
0.18%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 35 Schemes (9.68%)

FIIs

Held by 150 FIIs (12.07%)

Promoter with highest holding

Tata Sons Private Limited (31.9%)

Highest Public shareholder

Life Insurance Corporation Of India - P & Gs Fund (9.24%)

Individual Investors Holdings

24.12%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 23.76% vs -3.15% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 99.20% vs -2,192.47% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,255.00",
          "val2": "3,438.00",
          "chgp": "23.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "555.00",
          "val2": "274.00",
          "chgp": "102.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "148.00",
          "val2": "153.00",
          "chgp": "-3.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1,837.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.00",
          "val2": "-2,132.00",
          "chgp": "99.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.04%",
          "val2": "7.97%",
          "chgp": "5.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,596.00",
          "val2": "7,788.00",
          "chgp": "-2.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,186.00",
          "val2": "1,192.00",
          "chgp": "-0.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "291.00",
          "val2": "278.00",
          "chgp": "4.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-65.00",
          "val2": "15.00",
          "chgp": "-533.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "329.00",
          "val2": "344.00",
          "chgp": "-4.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.61%",
          "val2": "15.31%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -2.04% vs -4.75% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -18.90% vs -73.97% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,146.00",
          "val2": "11,378.00",
          "chgp": "-2.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,531.00",
          "val2": "1,626.00",
          "chgp": "-5.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "437.00",
          "val2": "426.00",
          "chgp": "2.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-119.00",
          "val2": "-55.00",
          "chgp": "-116.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "236.00",
          "val2": "291.00",
          "chgp": "-18.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.74%",
          "val2": "14.29%",
          "chgp": "-0.55%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -2.04% vs -3.46% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -906.81% vs -12.31% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,584.00",
          "val2": "14,887.00",
          "chgp": "-2.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,805.00",
          "val2": "1,953.00",
          "chgp": "-7.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "590.00",
          "val2": "563.00",
          "chgp": "4.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,956.00",
          "val2": "-92.00",
          "chgp": "-2,026.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,896.00",
          "val2": "235.00",
          "chgp": "-906.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.38%",
          "val2": "13.12%",
          "chgp": "-0.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
4,255.00
3,438.00
23.76%
Operating Profit (PBDIT) excl Other Income
555.00
274.00
102.55%
Interest
148.00
153.00
-3.27%
Exceptional Items
0.00
-1,837.00
100.00%
Consolidate Net Profit
-17.00
-2,132.00
99.20%
Operating Profit Margin (Excl OI)
13.04%
7.97%
5.07%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 23.76% vs -3.15% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 99.20% vs -2,192.47% in Mar 2026

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
7,596.00
7,788.00
-2.47%
Operating Profit (PBDIT) excl Other Income
1,186.00
1,192.00
-0.50%
Interest
291.00
278.00
4.68%
Exceptional Items
-65.00
15.00
-533.33%
Consolidate Net Profit
329.00
344.00
-4.36%
Operating Profit Margin (Excl OI)
15.61%
15.31%
0.30%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
11,146.00
11,378.00
-2.04%
Operating Profit (PBDIT) excl Other Income
1,531.00
1,626.00
-5.84%
Interest
437.00
426.00
2.58%
Exceptional Items
-119.00
-55.00
-116.36%
Consolidate Net Profit
236.00
291.00
-18.90%
Operating Profit Margin (Excl OI)
13.74%
14.29%
-0.55%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -2.04% vs -4.75% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -18.90% vs -73.97% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
14,584.00
14,887.00
-2.04%
Operating Profit (PBDIT) excl Other Income
1,805.00
1,953.00
-7.58%
Interest
590.00
563.00
4.80%
Exceptional Items
-1,956.00
-92.00
-2,026.09%
Consolidate Net Profit
-1,896.00
235.00
-906.81%
Operating Profit Margin (Excl OI)
12.38%
13.12%
-0.74%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -2.04% vs -3.46% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -906.81% vs -12.31% in Mar 2025

stock-summaryCompany CV
About Tata Chemicals Ltd. stock-summary
stock-summary
Tata Chemicals Ltd.
Small Cap
Commodity Chemicals
Tata Chemicals Limited (TCL) is a science-led sustainable chemistry solutions Company and is a part of the Tata Group. The Company operates through two verticals, Basic Chemistry (Alkali Chemicals-soda ash, sodium bicarb, salt, silica & other halogen chemicals) and Specialty Products (specialty silica, prebiotics & formulations, agrochemicals and seeds). It is a global player in soda ash and sodium bicarbonate with manufacturing facilities in India, US, UK and Kenya.
Company Coordinates stock-summary
Company Details
Bombay House, 24 Homi Mody Street Fort Mumbai Maharashtra : 400001
stock-summary
Tel: 91-22-66658282
stock-summary
investors@tatachemicals.com
Registrar Details
TSR Darashaw Ltd, 6-10 , Haji Moosa Patrawala Indl. Est , 20 Dr.E.Moses Road , Mahalaxmi , Mumbai